Skip to main content

ΙΩΑΝΝΗΣ Γ. ΓΡΙΒΕΑΣ

MD,PhD

Δημοσιεύσεις σε Διεθνή Περιοδικά

  • 47. Efficacy and tolerability of oral Sucrosomial® iron in CKD patients with anemia
    Ioannis Griveas
    Consultant Nephrologist 417 Veterans Army Administration
    Hospital of Athens, Medical Director Private Dialysis Unit
    ‘Nefroiatriki’, Athens, Greece,
    Private Renal Clinic ‘Athens-Nephrology’, Athens, Greece
    5th International multidisciplinary course on iron anemia, 31st March–1 April 2017, Florence, Italy.
    EXPERT REVIEW OF HEMATOLOGY, 2017 VOL. 10, NO. S1, 1–40
    https://doi.org/10.1080/17474086.2017.1399059
  • 48. HCV viraemia in anti-HCV-negative haemodialysis patients: Do we need HCV RNA detection test?
    Nikolaos Papadopoulos, Ioannis Griveas, Eirini Sveroni, Vasiliki Argiana, Antonios Kalliaropoulos, Beatriz Martinez-Gonzalez and Melanie Deutsch
    Int J Artif Organs. 2018 Mar;41(3):168-170
  • 49. Sucroferric oxyhydroxide: A novel phosphate binder for the management of mineral bone disease in dialysis patients
    Griveas I*, Sitaras P, Andriopoulos C and Aktsiali M
    Private Dialyis Unit “Nefroiatriki”
    Blood Heart Circ, Volume 3: 1-4, 2019
  • 50. The relation of parathyroid hormone and hematologic parameters under erythropoetin administration in hemodialysis patients
    Theodora Papachrysanthou, Maria Aktsiali, Ioannis Griveas, Christos Andriopoulos, Panagiotis Sitaras, George I. Lambrou
    Private Dialyis Unit “Nefroiatriki”
    JRPMS | September 2019 | Vol. 3, No. 3 | 106-112 106
  • 51. Treatment with cinacalcet in hemodialysis patients with severe secondary hyperparathyroidism influences bone mineral metabolism and anemia parameters
    Maria Aktsiali, Theodora Papachrysanthou, Ioannis Griveas, Christos Andriopoulos, Panagiotis Sitaras, Ioannis K. Triantafyllopoulos, George I. Lambrou*
    Private Dialyis Unit “Nefroiatriki”
    Current Drug Therapy 2019, DOI: 10.2174/1574885514666190802144629
  • 52. Efficacy and Tolerability of oral sucrosomial iron in CKD patients with anaemia and its association with CKD progression parameters
    Ioannis Griveas
    417 Army Share Fund Hospital, Athens, Greece
    Blood Tranfusion 17, Supplement no 1, March 2019
  • 53. The Importance of monitoring blood flow in the maintenance of vascular access in patients under hemodialysis
    Ioannis Griveas
    417 Army Share Fund Hospital, Athens, Greece
    JASN -ASN-Renal week , Washington DC, 5-10 November 2019
  • 54. Tumoral Calcinosis in hemodialysis patient
    Ioannis Griveas
    417 Army Share Fund Hospital, Athens, Greece
    JASN -ASN-Renal week , Washington DC, 5-10 November 2019
  • 55. Role of etelcalcetide in the management of secondary hyperparathyroidism in hemodialysis patients after 10 months therapy
    Ioannis Griveas
    417 Army Share Fund Hospital, Athens, Greece
    JASN -ASN-Renal week , Washington DC, 5-10 November 2019
  • 56. Paclitaxel - Coated Balloon Angioplasty for stenosis of access in Patients under Hemodialysis
    Ioannis Griveas
    417 Army Share Fund Hospital, Athens, Greece
    JASN -ASN-Renal week , Washington DC, 5-10 November 2019
  • 57. “PACLITAXEL-COATED BALLOON ANGIOPLASTY FOR STENOSIS OF ARTERIOVENOUS FISTULA IN PATIENTS UNDER HEMODIALYSIS: 18TH MONTH FOLLOW-UP”
    I. II. Griveas, G. Vourliotakis, I Kantounakis, et al.
    417 Army Share Fund Hospital of Athens, Greece
    Nephrology Dialysis and Transplantation , June 2020, Volume 35, Number 53
  • 58. “USE OF ASCORBATE-RICH DIALYSATE IN HEMODIALYSIS PATIENTS”
    I. Griveas
    417 Army Share Fund Hospital of Athens, Greece
    Nephrology Dialysis and Transplantation , June 2020, Volume 35, Number 53
  • 59. Heat-Shock Protein 27 kinetics in end stage renal disease patients
    I Griveas*
    Nephrology Department, 417 Army Share Fund Hospital (NIMTS), Athens, Greece
    Archives of Clinical Nephrology, September 2020
  • 60. Vascular Endothelial Growth Factor and Diabetic Nephropathy
    Ioannis Griveas*
    Nephrology Department in 417 Army Share Fund Hospital, Athens, Greece
    Biomedical Journal of Scientific and Technical Research, February 2020
  • 61. COVID-19 infection in patients receiving hemodialysis in Athens: Findings, experience, and outcome from a single Dialysis Unit
    Ioannis Griveas1 *, Antonios Schoinas1 , Anthi Balitsari1 , Gerasimos Asimakopoulos1 , Evaggelos Pratilas1
    Dept. of Nephrology, Army Share Fund Hospital of Athens 417 NIMTS, Greece
    Medical Science and Discovery, March 2021